Simulations Plus, Inc. ( NASDAQ: SLP) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Well, thank you, everybody, for being here today. I'm delighted to ...

Nimesh Khadka: Hot melt extrusion is widely used to improve drug solubility, bioavailability, and stability, but the process ...

Revolutionizing antibiotic discovery through artificial intelligence, halicin shows promise against resistant pathogens with ...

The Drug Discovery Outsourcing Market is set to grow at a 7.2% CAGR, driven by advanced technologies and increased demand for specialized expertise. NEWARK, DE, UNITED STATES, September 11, 2025 ...

Marine algae are a rich source of bioactive compounds with significant therapeutic potential, particularly in the field of cancer treatment. These bioactive ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that it ...

The International Society for Stem Cell Research (ISSCR) convened its first-ever meeting with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and Korea’s Ministry of Food and Drug Safety ...

Amneal is a pharma brand with a diverse and growing drug portfolio, strong cash flow metrics, and an improving debt situation ...

Analysts have set 12-month price targets for Charles River, revealing an average target of $181.67, a high estimate of ...

Researchers boosted the production of useful chemicals in a fungus by altering gene expression, not the DNA itself.

Government aims to double bio-pharmaceutical exports by 2030 and develop three blockbuster new drugs, backed by bold regulatory reforms and support for industrial growth - - Approval review periods ...

Bead-based plasma proteomics workflows boost proteome coverage but are vulnerable to cellular contamination, highlighting the ...